Ensysce Competitors

Delisted . USA . 
Stock . Ensysce Biosciences
ENSCWDelisted Stock  USD 0.01  0.0008  8.16%   
Ensysce Biosciences competes with Ensysce Biosciences; as well as few others. The company classifies itself under Healthcare sector and is part of Biotechnology industry. Analyzing Ensysce Biosciences competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Ensysce Biosciences to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Ensysce Biosciences competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ensysce Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.010.01
Details
Intrinsic
Valuation
LowRealHigh
0.010.010.01
Details
Naive
Forecast
LowNextHigh
0.010.010.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.02
Details

Ensysce Biosciences Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Ensysce Biosciences and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Ensysce and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Ensysce Biosciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
KTTAW
+ 0.53
ENSC
KTTAW
+ 0.47
NRXPW
NRXPW
+ 0.3
ENSC
EFTRW
+ 0.0
ENSC
EFTRW
+ 0.0
NRXPW
EFTRW
+ 0.0
KTTAW
  
High negative correlations   
FFIEW
- 0.53
KTTAW
FFIEW
- 0.5
ENSC
FFIEW
- 0.3
NRXPW
EFTRW
- 0.0
FFIEW
EFTRW
- 0.0
KTTAW
EFTRW
- 0.0
NRXPW

Risk-Adjusted Indicators

There is a big difference between Ensysce Pink Sheet performing well and Ensysce Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ensysce Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Ensysce Biosciences Competitive Analysis

The better you understand Ensysce Biosciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Ensysce Biosciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Ensysce Biosciences' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ENSCW ENSC NRXPW KTTAW FFIEW EFTRW
 8.16 
 0.01 
Ensysce
 1.89 
 8.10 
Ensysce
 10.56 
 0.07 
NRx
 0.00 
 0.02 
Pasithea
 11.11 
 0.02 
Faraday
 0.00 
 0 
EFFECTOR
Market Volatility
(90 Days Market Risk)
Very steady
Dangerous
Out of control
Out of control
Out of control
Very steady
Market Performance
(90 Days Performance)
Very Weak
OK
Modest
Good
Insignificant
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
High
High
Quite High
Very High
Dangerous
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Cautious Hold
Not Rated
Hold
Not Rated
Current Ratio
N/A
0.87 X
4.58 X
37.55 X
N/A
N/A
Net Asset
16.42 M
2.71 M
7.32 M
26.12 M
530.54 M
20.54 M
EBITDA
(27.79 M)
(10.72 M)
(30.02 M)
(15.33 M)
(383.13 M)
(33.73 M)
Operating Margin
N/A
(10.76) %
N/A
N/A
N/A
N/A
Current Valuation
N/A
6.71 M
N/A
N/A
N/A
N/A
Price To Book
N/A
1.52 X
N/A
N/A
N/A
N/A
Retained Earnings
N/A
(121.56 M)
(253.15 M)
(35.32 M)
(3.96 B)
(179.38 M)
Beta
N/A
0.64
1.27
0.82
1.95
0.62
Number Of Employees
6
7
N/A
8
586
14
Shares Outstanding
N/A
1.3 M
N/A
N/A
N/A
N/A
Cash Flow From Operations
(8.24 M)
(10.78 M)
(21.66 M)
(13.43 K)
(278.18 M)
(29.55 M)
Total Debt
4.44 M
854.7 K
9.16 M
81.68 K
144.32 M
19.45 M
Return On Equity
N/A
-4.28
-6.83
-0.63
-1.47
-9.47
Z Score
-3.3
N/A
N/A
N/A
N/A
N/A
Return On Asset
N/A
-1.32
-1.16
-0.38
-0.4
-0.83
Number Of Shares Shorted
N/A
1.73 M
3.94 K
128
16.34 K
18.44 K
Book Value Per Share
N/A
(0.10) X
(1.42) X
22.46 X
0.29 X
0.21 X
Total Asset
16.42 M
2.71 M
7.32 M
26.12 M
530.54 M
20.54 M
Debt To Equity
N/A
6.91 %
0.02 %
N/A
N/A
N/A
Short Ratio
N/A
0.12 X
N/A
N/A
N/A
N/A
Target Price
N/A
102.0
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
22.26 %
N/A
N/A
N/A
N/A
Market Capitalization
N/A
10.57 M
714.61 M
N/A
N/A
N/A
Price To Sales
N/A
7.35 X
N/A
N/A
N/A
N/A
Net Income
(29.15 M)
(10.63 M)
(30.15 M)
(15.51 M)
(431.74 M)
(35.81 M)
Earnings Per Share
N/A
(29.10) X
(6.25) X
N/A
(2.24) X
(0.91) X
Shares Owned By Insiders
N/A
1.17 %
N/A
N/A
N/A
N/A
Revenue
N/A
2.23 M
N/A
486.56 K
784 K
N/A
Working Capital
N/A
(1.04 M)
(12.16 M)
14.06 M
(169.81 M)
(5.96 M)
Cash And Equivalents
N/A
3.15 M
24.55 M
568.98 K
N/A
N/A
Cash Per Share
N/A
0.10 X
0.36 X
0.07 X
N/A
N/A
Gross Profit
N/A
(1.16 M)
N/A
N/A
N/A
N/A
Day Typical Price
0.0086
8.06
0.068
0.023
0.02
0.001
Accumulation Distribution
0.29
0.13
0.0429
N/A
0.18
N/A
Market Facilitation Index
0.0028
1.1
0.003
N/A
0.004
N/A
Daily Balance Of Power
(0.29)
0.1364
2.133333
0.0
0.5
0.0
Period Momentum Indicator
(0.0008)
0.15
0.0064
N/A
0.002
N/A
Rate Of Daily Change
0.92
1.02
1.11
1.0
1.11
1.0
Day Median Price
0.0084
8.04
0.0685
0.023
0.02
0.001
Price Action Indicator
2.0E-4
0.13
0.0017
N/A
0.001
N/A
Relative Strength Index
50.43
46.51
57.77
57.8
49.54
34.51
Coefficient Of Variation
N/A
947.44
2511.91
498.73
1875.26
N/A
Mean Deviation
N/A
11.97
8.95
21.16
9.26
N/A
Jensen Alpha
N/A
2.5
0.4384
6.07
0.6403
N/A
Total Risk Alpha
N/A
1.83
0.1385
5.13
0.307
N/A
Sortino Ratio
N/A
0.2511
0.029
0.2463
0.0602
N/A
Downside Variance
N/A
96.81
260.92
581.88
111.45
N/A
Standard Deviation
N/A
23.71
12.58
29.8
12.52
N/A
Kurtosis
N/A
31.8
0.6205
1.37
1.13
N/A
Potential Upside
N/A
26.55
24.11
62.34
25.87
N/A
Treynor Ratio
N/A
(22.85)
0.2077
(1.28)
0.8424
N/A
Maximum Drawdown
N/A
189.26
58.29
141.61
61.87
N/A
Variance
N/A
562.2
158.27
887.79
156.73
N/A
Market Risk Adjusted Performance
N/A
(22.84)
0.2177
(1.27)
0.8524
N/A
Risk Adjusted Performance
N/A
0.0933
0.0409
0.1686
0.0516
N/A
Skewness
N/A
4.92
(0.24)
1.13
0.9197
N/A
Semi Deviation
N/A
9.14
12.37
16.14
9.5
N/A
Information Ratio
N/A
0.1042
0.0373
0.1994
0.0508
N/A
Value At Risk
N/A
(16.67)
(24.81)
(31.89)
(15.42)
N/A
Expected Short fall
N/A
(18.20)
(9.73)
(32.98)
(11.57)
N/A
Downside Deviation
N/A
9.84
16.15
24.12
10.56
N/A
Semi Variance
N/A
83.58
152.97
260.35
90.24
N/A

Ensysce Biosciences Competition Performance Charts

Five steps to successful analysis of Ensysce Biosciences Competition

Ensysce Biosciences' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Ensysce Biosciences in relation to its competition. Ensysce Biosciences' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Ensysce Biosciences in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Ensysce Biosciences' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Ensysce Biosciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Ensysce Biosciences position

In addition to having Ensysce Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Tech Funds Thematic Idea Now

Tech Funds
Tech Funds Theme
Funds or Etfs that invest in companies involved in research, development, testing, or distribution of technologically based goods and services. The Tech Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Ensysce Pink Sheet

If you are still planning to invest in Ensysce Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ensysce Biosciences' history and understand the potential risks before investing.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Stocks Directory
Find actively traded stocks across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY